Jazz Pharmaceuticals (JAZZ) Current Deferred Revenue (2010 - 2023)
Jazz Pharmaceuticals' quarterly Current Deferred Revenue came in at $4000.0 in Q3 2023, down 99.54% year-on-year from $871000.0 in Q3 2022, and little changed quarter-over-quarter from $4000.0 in Q2 2023.
Jazz Pharmaceuticals has reported Current Deferred Revenue for 14 years, with the latest figure at $4000.0 in Q3 2023.
- For the quarter ending Q3 2023, Current Deferred Revenue fell 99.54% year-over-year to $4000.0; the trailing twelve-month figure through Sep 2023 stood at $4000.0 (down 99.54% YoY), and the FY2022 full-year result was $463000.0, down 77.88% from the prior year.
- Current Deferred Revenue for Q3 2023 stood at $4000.0, roughly flat from $4000.0 in the prior quarter.
- The five-year high for Current Deferred Revenue was $11.9 million in Q2 2019, with the low at $4000.0 in Q1 2023.
- Average Current Deferred Revenue over 5 years is $3.6 million, with a median of $3.6 million recorded in 2020.
- Year-over-year, Current Deferred Revenue soared 84.96% in 2019 and tumbled 99.76% in 2023.
- Tracing JAZZ's Current Deferred Revenue over 5 years: stood at $4.7 million in 2019, then gained by 2.99% to $4.9 million in 2020, then slumped by 56.94% to $2.1 million in 2021, then slumped by 77.88% to $463000.0 in 2022, then slumped by 99.14% to $4000.0 in 2023.
- The last three Current Deferred Revenue figures came in at $4000.0 (Q3 2023), $4000.0 (Q2 2023), and $4000.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 463,000.00 |
| Sep 30, 2022 | 871,000.00 |
| Jun 30, 2022 | 1.51 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 2.09 Mn |
| Sep 30, 2021 | 2.27 Mn |
| Jun 30, 2021 | 3.95 Mn |
| Mar 31, 2021 | 4.23 Mn |
| Dec 31, 2020 | 4.86 Mn |
| Sep 30, 2020 | 6.04 Mn |
| Jun 30, 2020 | 3.63 Mn |
| Mar 31, 2020 | 4.18 Mn |
| Dec 31, 2019 | 4.72 Mn |
| Sep 30, 2019 | 10.76 Mn |
| Jun 30, 2019 | 11.94 Mn |
| Mar 31, 2019 | 4.72 Mn |
| Dec 31, 2018 | 5.41 Mn |
| Sep 30, 2018 | 5.94 Mn |
| Jun 30, 2018 | 6.46 Mn |
| Mar 31, 2018 | 6.98 Mn |
| Dec 31, 2017 | 24.73 Mn |
| Sep 30, 2017 | 8.62 Mn |
| Jun 30, 2017 | 8.58 Mn |
| Mar 31, 2017 | 8.59 Mn |
| Dec 31, 2016 | 1.12 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.43 Mn |
| Mar 31, 2016 | 1.38 Mn |
| Dec 31, 2015 | 1.37 Mn |
| Sep 30, 2015 | 1.33 Mn |
| Jun 30, 2015 | 1.33 Mn |
| Mar 31, 2015 | 1.14 Mn |
| Dec 31, 2014 | 1.14 Mn |
| Sep 30, 2014 | 1.14 Mn |
| Jun 30, 2014 | 1.14 Mn |
| Mar 31, 2014 | 1.14 Mn |
| Dec 31, 2013 | 1.14 Mn |
| Sep 30, 2013 | 1.14 Mn |
| Jun 30, 2013 | 1.14 Mn |
| Mar 31, 2013 | 1.14 Mn |
| Dec 31, 2012 | 1.14 Mn |
| Sep 30, 2012 | 1.94 Mn |
| Jun 30, 2012 | 2.01 Mn |
| Mar 31, 2012 | 1.14 Mn |
| Dec 31, 2011 | 1.14 Mn |
| Sep 30, 2011 | 1.14 Mn |
| Jun 30, 2011 | 1.37 Mn |
| Dec 31, 2010 | 1.27 Mn |